While the Novavax vaccine study is still ongoing, initial results show it is nearly 96% effective against the older coronavirus and nearly 86% effective against the new variant circulating in the UK.
Novavax says its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious..
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to..